Edwards Lifesciences Corporation (EW) is a Healthcare stock trading at $87.36 (as of 2026-06-18), with a market capitalization of $50.62B and a trailing P/E of 46.8. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Edwards Lifesciences develops products and technologies for structural heart disease and for critical care and surgical monitoring. It supplies transcatheter solutions for valve replacement and repair (including mitral and tricuspid therapies), surgical structural heart products, and hemodynamic monitoring and hypotension prediction software for clinicians in hospitals.